Published in Antimicrob Agents Chemother on October 01, 1987
Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol (2010) 2.00
Vancomycin pharmacokinetics in burn patients and intravenous drug abusers. Antimicrob Agents Chemother (1990) 1.32
Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med (1982) 4.16
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother (1983) 2.99
In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci. Antimicrob Agents Chemother (1973) 2.58
Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann Intern Med (1982) 2.05
A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother (1985) 1.64
Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother (1982) 1.43
Vancomycin. A second look. JAMA (1977) 1.38
Pharmacokinetics of vancomycin. J Antimicrob Chemother (1984) 1.24
Vancomycin enhancement of experimental tobramycin nephrotoxicity. Antimicrob Agents Chemother (1986) 1.24
Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin. Clin Chim Acta (1981) 1.18
Renal tolerance and pharmacokinetics of vancomycin in rats. J Antimicrob Chemother (1984) 1.17
Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother (1981) 1.17
An optimized assay of alanine aminopeptidase activity in urine. Clin Chem (1980) 1.03
Quantitative nephrotoxicity of gentamicin in nontoxic doses. J Infect Dis (1980) 0.99
Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum. Clin Chim Acta (1981) 0.99
Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin. Antimicrob Agents Chemother (1983) 0.95
Immune responses to pneumococcal polysaccharide antigens: a comparison of the murine model and the response in humans. Rev Infect Dis (1981) 0.88
Immunochemical studies of human beta 2-microglobulin. A review of recent methodological progress and clinical applications. Allergy (1980) 0.86
Aminoglycoside nephrotoxicity and its predictability. Nephron (1981) 0.80
Serum beta 2-microglobulin. Mayo Clin Proc (1986) 0.79
Additive toxicity in patients receiving vancomycin and aminoglycosides. Clin Pharm (1984) 0.78
Clinical pharmacology of aminoglycoside antibiotics in pediatrics. Pediatr Clin North Am (1983) 0.78
Renal toxicity during therapy with gentamicin or tobramycin. Mayo Clin Proc (1981) 0.78
Animal studies on the reduction of aminoglycoside-induced nephrotoxicity by D-glucaro-1,5-lactam. Infection (1983) 0.77
Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis (2010) 2.60
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.35
Cloning and characterization of a phosphopantetheinyl transferase from Streptomyces verticillus ATCC15003, the producer of the hybrid peptide-polyketide antitumor drug bleomycin. Chem Biol (2001) 2.25
Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother (1990) 2.06
Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1989) 1.64
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon. Clin Pharmacol Ther (1983) 1.43
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos (1997) 1.43
Problems in regaining full extension of the knee after anterior cruciate ligament reconstruction: does arthrofibrosis exist? Knee Surg Sports Traumatol Arthrosc (1994) 1.41
Primary Cancer of the Lung. Cal West Med (1945) 1.38
Antidepressant use during breastfeeding. J Hum Lact (1996) 1.37
Vancomycin pharmacokinetics in burn patients and intravenous drug abusers. Antimicrob Agents Chemother (1990) 1.32
Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrob Agents Chemother (1991) 1.29
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1990) 1.29
Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther (1995) 1.28
Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit (1994) 1.24
Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther (1982) 1.23
Effects of a three-year exercise program on motor function and cognitive processing speed in older women. Res Q Exerc Sport (1991) 1.19
Comparison of chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans. J Pharm Sci (1982) 1.18
Trough concentrations of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol (1993) 1.15
Increased theophylline concentrations secondary to ciprofloxacin. Drug Intell Clin Pharm (1987) 1.13
A model of insulin fibrils derived from the x-ray crystal structure of a monomeric insulin (despentapeptide insulin). Proteins (1997) 1.07
Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1989) 1.05
Visual expectation and dimensions of infant information processing. Child Dev (1992) 1.04
Vancomycin protein binding in patients with infections caused by Staphylococcus aureus. DICP (1991) 1.03
Effect of norfloxacin on theophylline pharmacokinetics at steady state. Antimicrob Agents Chemother (1988) 1.02
Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim. Am J Hematol (2001) 1.02
One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol. Life Sci (1992) 0.97
Clinical pharmacokinetics of oral cephalosporins. Antibiot Chemother (1971) (1995) 0.96
Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man. Br J Clin Pharmacol (1992) 0.96
Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues. Biochemistry (1998) 0.95
Coagulase-negative staphylococci: incidence, pathogenicity, and treatment in the 1990s. DICP (1990) 0.95
The biosynthetic gene cluster for the anticancer drug bleomycin from Streptomyces verticillus ATCC15003 as a model for hybrid peptide-polyketide natural product biosynthesis. J Ind Microbiol Biotechnol (2001) 0.93
Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1991) 0.93
Recent advances: the cytochrome P450 enzymes. Ann Pharmacother (1995) 0.92
Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557. Antimicrob Agents Chemother (2009) 0.92
Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later. Psychopharmacology (Berl) (1989) 0.90
Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin. Clin Pharmacol Ther (1995) 0.90
Endometrial cancer metastasis presenting as a grossly swollen toe. Int J Gynecol Cancer (2003) 0.90
Bioavailability of syrup and tablet formulations of cefetamet pivoxil. Antimicrob Agents Chemother (1993) 0.90
Factors affecting quinidine protein binding in humans. J Pharm Sci (1984) 0.89
In vitro interactions between beta-lactam antibiotics and tobramycin. Clin Chem (1981) 0.89
Aromatic acids derived from phenylalanine in the tissues of rats with experimentally induced phenylketonuria-like characteristics. Biochem J (1972) 0.89
Adrenal epinephrine and norepinephrine release to hypoglycemia measured by microdialysis in conscious rats. Am J Physiol (1997) 0.88
Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy. Int J Antimicrob Agents (1992) 0.88
Transcranial direct current stimulation (tDCS) and robotic practice in chronic stroke: the dimension of timing. NeuroRehabilitation (2013) 0.87
Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics. Biochem J (1973) 0.86
A radiological method for producing precise limb alignment. J Bone Joint Surg Br (1991) 0.86
Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs. Eur J Clin Pharmacol (1983) 0.84
Triphosphopyridine nucleotide specific isocitrate dehydrogenase from Azotobacter vinelandii. Alkylation of a specific methionine residue and amino acid sequence of the peptide containing this residue. Biochemistry (1974) 0.84
Predicted tissue accumulation of netilmicin in patients. Antimicrob Agents Chemother (1981) 0.84
Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration. J Clin Pharmacol (1996) 0.83
Effect of buprenorphine on CYP3A activity in rat and human liver microsomes. Life Sci (2000) 0.83
The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine. Clin Pharmacol Ther (1987) 0.83
The pharmacokinetics of meperidine in acute trauma patients. J Trauma (1986) 0.83
Clinical pharmacokinetics of pethidine: 1982. Clin Pharmacokinet (1983) 0.83
Pharmacokinetics of tranylcypromine in patients who are depressed: relationship to cardiovascular effects. Clin Pharmacol Ther (1986) 0.82
The effects of imipramine and iprindole on the metabolism of octopamine in the rat. Neuropharmacology (1985) 0.82
The effects of lithium on a potential cycling model of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.82
Some aspects of the epidemiology of equine salmonellosis. Aust Vet J (1988) 0.82
Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients. Br J Clin Pharmacol (1987) 0.81
Phenylethylamine: evidence for a direct, postsynaptic dopamine-receptor stimulating action. Brain Res (1977) 0.81
Effects of experience in a dynamic environment on postural control. Br J Sports Med (2007) 0.81
Crystal structure of a chimeric Fab' fragment of an antibody binding tumour cells. J Mol Biol (1992) 0.81
Simultaneous quantitation of disopyramide and its mono-dealkylated metabolite in human plasma by fused-silica capillary gas chromatography using nitrogen-phosphorus specific detection. J Chromatogr (1984) 0.80
Changes in plasma levels of calcium and in bone marrow mitosis after antigenic challenge in rats and mice. J Endocrinol (1981) 0.80
Evaluation of dosage-release formulations on inhibition of drug clearance: effect of sustained- and immediate-release verapamil on propranolol pharmacokinetic parameters. Ther Drug Monit (1994) 0.80
The effect of verapamil on antipyrine pharmacokinetics and metabolism in man. Br J Clin Pharmacol (1986) 0.80
Serum requirement for growth and immunoglobulin synthesis by cultured human lymphocyte lines. Dev Biol Stand (1979) 0.79
Adrenal medullary catecholamine secretion patterns in rats evoked by reflex and direct neural stimulation. Clin Exp Hypertens (2000) 0.79
Protein binding characteristics of bumetanide. Dev Pharmacol Ther (1989) 0.79
Applicability of capillary gas liquid chromatography to the measurement of free fraction of disopyramide in human plasma. Res Commun Chem Pathol Pharmacol (1985) 0.79
Analysis of phenylethylamines in biological tissues by gas-liquid chromatography with electron-capture detection. Anal Biochem (1972) 0.78
Long-term oscillation of corticosterone following intermittent cocaine. J Neural Transm (Vienna) (2000) 0.78
One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Res (1991) 0.78
Effects of L-dopa on dopamine and norepinephrine concentrations in rat brain assessed by gas chromatography. J Chromatogr (1981) 0.78
Determination of urinary methylhistamine excretion in male and female rats by gas chromatography with electron-capture detection. Life Sci (1980) 0.78
Defensive hostility and coronary heart disease: a preliminary investigation of male veterans. Psychosom Med (2001) 0.78
Stressor-induced oscillation. A possible model of the bidirectional symptoms in PTSD. Ann N Y Acad Sci (1997) 0.78
Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions. J Clin Psychopharmacol (1990) 0.78
Oscillatory-sensitization model of repeated drug exposure: cocaine's effects on shock-induced hypoalgesia. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.78
Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine. Biochem Med (1981) 0.78
Studies of information processing in sleep. Psychophysiology (1975) 0.78
Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment: possibly a major factor in drug variability. Neuropsychopharmacology (1995) 0.78
Behavioral effects of a single neuroleptic treatment grow with the passage of time. Brain Res (1986) 0.78
Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stressful/foreign nature of drugs. Psychopharmacology (Berl) (1992) 0.77
Analysis of messages expressed by Echinostoma paraensei miracidia and sporocysts, obtained by random EST sequencing. J Parasitol (2000) 0.77
The in vivo formation of p-chloro- -phenylethylamine in young rats injected with p-chlorophenylalanine. J Neurochem (1972) 0.77
The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus. Pharmacotherapy (1997) 0.77
High-dose omeprazole: use of a multiple-dose study design to assess bioequivalence and accuracy of CYP2C19 phenotyping. Ther Drug Monit (1999) 0.77
Subcellular localization of types A and B monoamine oxidase in rat brain. Biochem Pharmacol (1977) 0.77
Stress reverse the anorexia induced by amphetamine and methylphenidate but not fenfluramine. Brain Res (1978) 0.77
Selective radiochemical labeling of types A and B active sites of rat liver monoamine oxidase. Biochem Biophys Res Commun (1979) 0.77
Multiple forms of monoamine oxidase in rabbit platelets. Life Sci (1975) 0.77
Reactions of the isolated plaice stomach to applied drugs. Comp Gen Pharmacol (1972) 0.77
Opposite effects of chronic imipramine treatment on brain and urine MHPG levels in the rat. Biol Psychiatry (1985) 0.77
Immobilization 12 days (but not one hour) earlier enhanced 2-deoxy-D-glucose-induced immunosuppression: evidence for stressor-induced time-dependent sensitization of the immune system. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.76
Oscillatory effects of repeated morphine on shock-induced hypoalgesia and beta-endorphin. Synapse (1998) 0.76
Possible role of octopamine and tyramine in the antihypertensive and antidepressant effects of tyrosine. Life Sci (1982) 0.76
The effect of a single oral dose of ethanol on hepatic blood flow in man. Eur J Clin Pharmacol (1987) 0.76